The MSL Society
is proud once again to have an expert-packed speaker lineup for its Paris 2013 event in October. Among the panel of speakers from the world of
medical affairs is the dynamic director of medical affairs at Sequenom,
Elizabeth holds a Doctor of
Philosophy (Ph.D.) from the University of Texas at Austin in Women’s Health,
with an additional interdisciplinary portfolio in Women’s and Gender Studies.
She earned her undergraduate and graduate degrees from the University of Texas
Medical Branch in Galveston. In addition
to her role at Sequenom, a life sciences leader in genetic analysis solutions, Elizabeth
serves as Adjunct Assistant Clinical Professor of Nursing at the University of
Texas at Austin.
During her 35-year career, Elizabeth has gained a vast amount
of clinical experience in many areas of women’s health, beginning as a
registered nurse in labor & delivery, with progressive management roles up
to the director level. She practiced for eight years as a women's health nurse
practitioner (WHNP), and has taught at the graduate level.
Most recently, she has worked in the life sciences industry
for 11 years in medical affairs. Elizabeth has been an author and co-author of
peer-reviewed journal publications in the Women’s Health field and has
presented clinical, medical, and scientific information to small and large
groups at local, national, and international venues. .
The MSL Society Blog
sat down with Dr. Kupferer to discuss her upcoming presentation at Paris 2013.
The MSL Society Blog:
What topic will you be speaking about at Paris 2013?
Kupferer: I will be sharing about my professional experience with
establishing a Medical Affairs department and MSL team in a Molecular
Diagnostics Laboratory setting.
The MSL Society Blog:
Why do you think this is important in the world of MSLs?
Kupferer: This topic is important is because it illustrates the
value of the addition of a Medical Affairs Department and MSL team in an
industry that is not highly-regulated. My department and MSL team was the first
of its kind in the pre-natal diagnostics space and has now been replicated by
our competitors. HCP education is integral in molecular diagnostics and genetic
testing because of the rapid and continued advancement in diagnostic
technologies that are literally driving changes to clinical practice. It is
important for health care providers to understand how the technologies work and
how they can be integrated into practice appropriately and ethically.
The MSL Society Blog: What's the single-most important trend you
see on the horizon with regard to the role of MSLs?
Kupferer: I believe the
biggest impact on the MSL role is the increasing complexity of pharmaceuticals,
devices and the advancement of personalized medicine and genomics. This
opens up more opportunities for highly-educated experts in each of these
The MSL Society Blog: What's the most important piece of advice you
could give to a new MSL today?
Kupferer: Stay curious and
embrace change. Flexibility and adapting to change are integral to the MSL
now for MSL Society Paris 2013 at the event website, www.themsls.org/Paris-2013, for a great opportunity to learn
from leading experts like Elizabeth Kupferer, along with plenty of
opportunities to network with peers and executives across the global medical